Factors Associated with Positive Toxicology at Delivery: Insights From the University of Maryland Medical System
- PMID: 40402351
- DOI: 10.1007/s10995-025-04107-5
Factors Associated with Positive Toxicology at Delivery: Insights From the University of Maryland Medical System
Abstract
Objective: To explore factors associated with positive toxicology tests during birthing admissions within a hospital system employing universal toxicology testing.
Methods: A retrospective cross-sectional study from 2019 to 2022, within a health system where toxicology tests are performed routinely during the birth admission. Substance use was defined as a positive toxicology test and race was self-reported. The association between substance use with race and insurance was analyzed. Assessments were made using descriptive statistics, chi-squared tests, and logistic regression models, controlling for maternal age, gestational age, birth year, insurance, and birth hospital. Separate analyses were conducted excluding cannabis from the toxicology evaluations.
Results: Of 37,438 deliveries, 97% (36,323) underwent toxicology testing. Unadjusted odds for positive toxicology tests (including amphetamines, barbiturates, benzodiazepines, cannabis, cocaine, fentanyl, methadone, opioids (all), phencyclidine) were: Black (OR 1.91), Hispanic (OR 0.36), and Other (OR 0.56), compared with White. After adjusting for confounders, all groups showed decreased odds: Black (aOR 0.75), Hispanic (aOR 0.15), and Other (aOR 0.36). For insurance, the unadjusted odds were compared to private insurance: Public (OR 4.18) and Other (OR 1.81). When excluding cannabis, unadjusted odds for Black individuals increased (OR 1.21) while adjusted odds for Black, Hispanic, and 'Other' groups decreased relative to White individuals.
Conclusion: Substance use during pregnancy exhibits sociodemographic variations. Initial unadjusted findings indicated racial disparities in substance use. However, adjusted models shifted these initial observations. Findings highlight the intertwined nature of sociodemographic factors in toxicology test results. Study findings underscore the need for comprehensive research to inform interventions, focusing on racial and socioeconomic inequities.
Keywords: Cannabis in pregnancy; Health disparities; Insurance; Perinatal equity; Race; Structural determinants of health; Substance use in pregnancy; Universal toxicology testing.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest.
Similar articles
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
-
Maternal and neonatal outcomes of elective induction of labor.Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Evid Rep Technol Assess (Full Rep). 2009. PMID: 19408970 Free PMC article.
-
Content Analysis of Maternal Toxicology Testing Policies to Inform Equity in Substance Use Disorder Identification.Matern Child Health J. 2025 Jun;29(6):799-807. doi: 10.1007/s10995-025-04104-8. Epub 2025 May 16. Matern Child Health J. 2025. PMID: 40377768
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
References
-
- Akinyemi, O. A., Adetokunbo, S., Elleissy Nasef, K., Ayeni, O., Akinwumi, B., & Fakorede, M. O. (2022). Interaction of maternal race/ethnicity, insurance, and education level on pregnancy outcomes: A retrospective analysis of the united States vital statistics records. Cureus, 14(4), e24235. https://doi.org/10.7759/cureus.24235 - DOI - PubMed - PMC
-
- Besse, M., Parikh, K., & Mark, K. (2023). Reported reasons for Cannabis use before and after pregnancy recognition. Journal of Addiction Medicine, 17(5), 563–567. https://doi.org/10.1097/ADM.0000000000001178 - DOI - PubMed
-
- Chasnoff, I. J., Landress, H. J., & Barrett, M. E. (1990). The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. New England Journal of Medicine, 322(17), 1202–1206. https://doi.org/10.1056/nejm199004263221706 - DOI - PubMed
-
- Chiandetti, A., Hernandez, G., Mercadal-Hally, M., Alvarez, A., Andreu-Fernandez, V., Navarro-Tapia, E., & Garcia-Algar, O. (2017). Prevalence of prenatal exposure to substances of abuse: Questionnaire versus biomarkers. Reprod Health, 14(1), 137. https://doi.org/10.1186/s12978-017-0385-3 - DOI - PubMed - PMC
-
- Clinical guidance for treating. (2019). Pregnant and parenting women with opioid use disorder and their infants. Medicaid managed care. SAMHSA.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical